Literature DB >> 12648735

The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis.

Robin Emsley1, Jonathan Rabinowitz, Martijn Torreman.   

Abstract

The Positive and Negative Syndrome Scale (PANSS) is a widely used instrument for measuring severe psychopathology in adult patients with schizophrenia. Data, primarily on chronic patients, have been used to define factors for the PANSS. The present study examines the PANSS factor structure in a large sample of subjects with recent-onset schizophrenia, schizophreniform disorder and schizoaffective disorder who had been exposed to very limited antipsychotic medication. Equamax factor analysis was conducted on PANSS baseline assessments from a multicenter, 11 country drug trial that enrolled 535 patients. The forced five-factor solution essentially corresponds to the factors most frequently described previously, namely negative, positive, disorganized (or cognitive), excited and anxiety/depression. In the exploratory analysis, a seven-factor solution was obtained, with depression and anxiety symptoms separating and a motor component emerging. The results of this study partially support the use of a five-factor model for the PANSS, but suggest that scales for catatonia, depressive and anxiety syndromes should be included in future studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12648735     DOI: 10.1016/s0920-9964(02)00302-x

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  88 in total

1.  Suicidal behavior and insight into illness among patients with schizophrenia spectrum disorders.

Authors:  Yu-Chen Kao; Yia-Ping Liu
Journal:  Psychiatr Q       Date:  2011-09

Review 2.  Categorical vs dimensional classifications of psychotic disorders.

Authors:  Melissa Potuzak; Caitlin Ravichandran; Kathryn E Lewandowski; Dost Ongür; Bruce M Cohen
Journal:  Compr Psychiatry       Date:  2012-06-07       Impact factor: 3.735

Review 3.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

Review 4.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

5.  A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia.

Authors:  Peter D Alexander; Kristina M Gicas; Alex Cheng; Donna J Lang; Ric M Procyshyn; Alexandra T Vertinsky; William J Panenka; Allen E Thornton; Alexander Rauscher; Jamie Y X Wong; Tasha Chan; Andrea A Jones; F Vila-Rodriguez; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2019-06-22       Impact factor: 4.530

6.  A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.

Authors:  Peter D Alexander; Kristina M Gicas; Taylor S Willi; Clara N Kim; Veronika Boyeva; Ric M Procyshyn; Geoff N Smith; Allen E Thornton; William J Panenka; Andrea A Jones; Fidel Vila-Rodriguez; Donna J Lang; G William MacEwan; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2017-02-11       Impact factor: 4.530

Review 7.  Progress in defining optimal treatment outcome in schizophrenia.

Authors:  Gary Remington; George Foussias; Ofer Agid
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

8.  Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment.

Authors:  Stefan Klingberg; Andreas Wittorf; Jutta Herrlich; Georg Wiedemann; Christoph Meisner; Gerhard Buchkremer; Nicole Frommann; Wolfgang Wölwer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

9.  Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis.

Authors:  Todd S Woodward; Kwanghee Jung; Geoffrey N Smith; Heungsun Hwang; Alasdair M Barr; Ric M Procyshyn; Sean W Flynn; Mark van der Gaag; William G Honer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-10-15       Impact factor: 5.270

10.  Sparse factors for the positive and negative syndrome scale: which symptoms and stage of illness?

Authors:  Ariana Anderson; Marsha Wilcox; Adam Savitz; Hearee Chung; Qingqin Li; Giacomo Salvadore; Dai Wang; Isaac Nuamah; Steven P Riese; Robert M Bilder
Journal:  Psychiatry Res       Date:  2015-01-06       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.